On May 20, SAMSONITE (01910) spent HKD 19,745,600 to repurchase 1,360,800 shares.
Samsonite (01910) announced that the company repurchased 1.3608 million shares at a cost of HK$ 19.7456 million on May 20, 2026, with a repurchase price range of HK$14.32-14.64 per share.
SAMSONITE (01910) announced that the company bought back 1,360,800 shares on May 20, 2026, at a total cost of HK$19.7456 million, with a buyback price ranging from HK$14.32 to HK$14.64 per share.
Related Articles
CHINA TRAVEL HK (00308) plans to spin off its Hong Kong and Macau tourism business through physical distribution, and to introduce them as independent listings on the Main Board of the Hong Kong Stock Exchange.
XUNZHONG (02597) intends to transfer 49% equity of its subsidiary Jiangsu Hongluo.
Meiwei Biological - B (02493): Maiwei Health Injection supplementary indications application approved by the National Medical Products Administration.
CHINA TRAVEL HK (00308) plans to spin off its Hong Kong and Macau tourism business through physical distribution, and to introduce them as independent listings on the Main Board of the Hong Kong Stock Exchange.
XUNZHONG (02597) intends to transfer 49% equity of its subsidiary Jiangsu Hongluo.
Meiwei Biological - B (02493): Maiwei Health Injection supplementary indications application approved by the National Medical Products Administration.
